Safety and Immunogenicity of rSh28GST Antigen in Humans: Phase 1 Randomized Clinical Study of a Vaccine Candidate against Urinary Schistosomiasis

Title
Safety and Immunogenicity of rSh28GST Antigen in Humans: Phase 1 Randomized Clinical Study of a Vaccine Candidate against Urinary Schistosomiasis
Authors
Keywords
Alumni, Adverse events, Vaccines, Antibodies, Bilirubin, Comparators, Phase I clinical investigation, Antibody response
Journal
PLoS Neglected Tropical Diseases
Volume 6, Issue 7, Pages e1704
Publisher
Public Library of Science (PLoS)
Online
2012-07-04
DOI
10.1371/journal.pntd.0001704

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now